Aquestive Therapeutics (AQST) vs CorMedix (CRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Aquestive Therapeutics (AQST) has outperformed CorMedix (CRMD) over the past year, losing 22.6% versus a loss of 34.4%. Over five years, CRMD leads with a +47.1% price change compared with +19.4% for AQST. Aquestive Therapeutics is the larger company by market cap ($579.9 million vs $567.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AQST | CRMD |
|---|---|---|
| Share price | $4.62 | $7.28 |
| Market cap | $579.86M | $567.43M |
| 1-day change | +0.22% | 0.00% |
| YTD return | -28.48% | -37.40% |
| 1-year return | -22.61% | -34.36% |
| 5-year return | +19.38% | +47.07% |
| P/E ratio (TTM) | — | 3.55 |
| Forward P/E | — | 20.80 |
| EPS (TTM) | $-0.66 | $2.05 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.55 | $13.02 |
| 52-week low | $2.93 | $6.13 |
| Distance from 52-week high | -38.81% | -44.09% |
| Average volume | 2.66M | 1.06M |
| Shares outstanding | 125.51M | 77.94M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AQST has outperformed CRMD by 11.7 percentage points over the past year.
AQST vs CRMD FAQ
Which is bigger, Aquestive Therapeutics or CorMedix?
Aquestive Therapeutics (AQST) is larger, with a market capitalization of $579.86M compared with $567.43M for CorMedix (CRMD).
Which stock has performed better over the past year, AQST or CRMD?
AQST returned -22.61% over the past 12 months, compared with -34.36% for CRMD (price return, excluding dividends). Past performance does not predict future results.
Are Aquestive Therapeutics and CorMedix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.